製藥
從元素/物相分析到分子結構解析
X光繞射(XRD)和 X光螢光(XRF)在藥物發現和品質控制中發揮著關鍵作用。理學在單晶繞射儀器領域表現卓越,這對於處理大分子和小分子都至關重要。我們提供從晶體篩選系統到三維結構精修的完整流程解決方案,全面滿足法規監管與非監管環境下的關鍵品質屬性控制需求。
藥品完整生命週期
以成熟可靠的材料分析、鑑定與定量技術,幫助您打造安全、高效、值得信賴的藥品。
藥物研發
理學為藥物研發提供全方面解決方案,透過解析導致疾病的蛋白質結構,協助設計新藥候選分子。小角度 X光散射儀(SAXS),以及適用於小分子的獨特 PDF 方法均可幫助您推進藥物研發進程。
瞭解更多 >
處方前研究
藥物研發、設計、開發及製劑研究的各個階段都高度依賴多種分析技術的綜合運用。這些技術包括:用於獲取結構訊息的繞射技術、解析分子細節的光譜技術、測定元素組成的螢光分析,以及判斷晶型的熱分析技術。
瞭解更多 >
製劑研發
製劑研發過程複雜多變,存在多種技術路徑與潛在風險。理學透過提供全面的分析工具與專業洞察,幫助您實現目標產品性能。我們的解決方案覆蓋原子純度、分子鑑定、空間結構、微觀結構與物相行為表徵,幫助製劑研究者取得精準數據。
瞭解更多 >
生產與品質控制
理學透過多種分析技術確保持續穩定的藥品質量。我們綜合運用螢光、光譜、繞射及定量分析方法,監測原料混合均勻度與固態形式轉變。此外,還可採用X光CT顯微成像解析三維微觀結構,建立其與溶出行為、治療效果的關聯模型,為藥品等效性研究提供關鍵依據。
瞭解更多 >下載醫藥應用電子書
應用領域
瞭解製藥分析的主要應用
多晶型研究
為全面掌握活性分子的固態形態特性,需進行系統的多晶型篩選,以識別可能存在的不同晶型、水合物/溶劑化物及共晶形式,並確認其熱力學相互關係。理學提供一系列可定製化的繞射、光譜及熱分析系統,以滿足從簡略到全面的篩選需求。
瞭解更多 >應用說明
探索成功應用案例,應對研發與生產中的挑戰
-
XRD1003 - How to Evaluate Solid Pharmaceutical Drugs (3): Confirming Hydrates
-
XRD1002 - How to Evaluate Solid Pharmaceutical Drugs (2): Confirming the Presence/absence of Amorphous Substances
-
XRD1001 - How to Evaluate Solid Pharmaceutical Drugs (1): Confirming the crystal form of an API
-
XCT2102 - Submicron CT for the Pharmaceutical Industry
-
TA6017 - Evolved Gas and Kinetic Analysis of Acetylsalicylic Acid
-
TA6006 - Thermal Behavior Analysis of Over-the-counter (OTC) Drugs
-
TA6005 - Comparison of Drugs
-
TA-TGMS-Pharm - TG-MS Analysis for Thermal Behavior of Commercialized PharmaceuticalProducts
-
SMX042 - In situ crystallization and diffraction experiments with the Insight Chips liquid nano-channel holder and XtaLAB Synergy-ED
-
SMX039 - The Absolute Structure of Light-atom-containing Molecules
-
SMX037 - Identification of a Fungicide Degradant using the XtaLAB Synergy-ED
-
SMX030 - Application of the Crystalline Sponge Method for Structure Determination of Persistent organic Pollutants of Agrochemical Degradation Products
-
SMX027 - Micro Powder Diffraction on XtaLAB Synergy Single Crystal Diffractometers
-
SMX010 - A Study of the Stereochemistry of Sucrose and a Phenidate Derivative using the Copper Microfocus Source of the XtaLAB Synergy-i
-
RAD006 - Pharmaceutical Excipients Identification with Handheld Raman
-
RACCT9045 - Tablet Crystallinity Analysis by X-ray CT
-
RACCT9044 - Rapid-release Pain Medication Capsule Comparison by X-ray CT
-
RACCT9043 - Multivitamin Tablet Analysis by X-ray CT
-
RACCT9042 - Microparticle Coating Analysis by X-ray CT
-
RACCT9041 - Famotidine Tablet Comparison by X-ray CT
-
RACCT9040 - Degradation of Sustained-release Dosage Tablet Imaged by X-ray CT
-
RACCT9039 - Compression Methods Comparison by X-ray CT
-
RACCT9038 - Brand Name vs Generic Atorvastatin Tablets Comparison by X-ray CT
-
RACCT9037 - Aspirin Tablet Coating Delamination Imaging by X-ray CT
-
PHRM0002 - In-Situ DSC-Humidity PXRD Analysis for Pharmaceuticals
-
PHRM0001 - Crystalline Sponge Method on XtaLAB Synergy Systems
-
EDXRF1933 - NEX DE Series—Catalysts Residue and Heavy Metal Screening in Pharma Formulation Process Chemistry
-
B-XRI1015 - Observation of Lyophilized Formulations by Micro X-ray CT
-
B-XRD1142 - Quantitative Analysis of Crystal Polymorphs by the DD Method
-
B-XRD1137 - Phase ID Analysis of Micro-impurities on the Surface of a Tablet by Micro-area XRD Measurements
-
B-XRD1133 - Observation of Phase Transition Behavior of Pharmaceutical Materials with a Benchtop XRD System
-
B-XRD1129 - Variable Humidity Measurement of a Drug Substance using XRD-DSC and a Humidity Controller
-
B-XRD1128 - Observation of Dehydration Behavior of a Drug Substance using TG-DTA and XRD-DSC
-
B-XRD1120 - Quantitative Analysis of Pharmaceutical Polymorphic Forms via the DD Method
-
B-XRD1114 - LOQ of Trace Impurities in API by the DD Method
-
B-XRD1081 - Quantitative Analysis of Polymorphic Impurities in a Drug Substance by the Calibration Method
-
B-XRD1060 - MiniFlex Measurement of Trace Samples
-
B-XRD1046 - Crystal Phase Identification of Pharmaceutical Materials in the Freeze Drying Process
-
B-XRD1043 - Powder Crystal Structure of Organic Crystals
-
B-XRD1035 - Crystal Structure Analysis of a Powder Sample of Pharmaceutical Cocrystals by the Rietveld Method
-
B-XRD1023 - Measurement of Pseudo-polymorph Impurities in Tablets
-
B-XRD1021 - Phase Changes of Pharmaceuticals as a Function of Temperature and Humidity
-
B-XRD1020 - Observation of Dehydration Process of Hydrate by XRD-DSC
-
B-TA2042 - Thermal Stability of Polyethylene Glycol Studied by TG-MS
-
B-TA1086 - Analysis of Polymorphic Transition of Carbamazepine -Sample Observation DSC, ChromTA (Chromatic Thermal Analysis)
-
B-TA1035 - Dehydration of Trehalose Dihydrate by STA
-
B-TA1027 - Water Absorption Behavior of Materials for Biomedical Application by HUM-TG
-
B-TA1013 - Mechanically Induced Amorphization in Trehalose Dihydrate by STA
-
B-TA1010 - Thermal Behavior of Caffeine by STA and DSC
-
B-TA1008 - Mechanochemical Effect in Caffeine
-
B-TA1003 - The Behavior of Water Absorption and Dehydration of Organic Materials
-
B-SCX1011 - High-Speed Measurement Of A Peptide Drug Using HyPix-Arc 150°